Consumer protection bill
This article was originally published in The Rose Sheet
Executive SummaryHR 2621 moves to the Senate after passing lower chamber June 11 by voice vote. Measure would amend the Federal Anti-Tampering Act by making it a crime to "knowingly stamp, print, place or insert any writing in or on any consumer product...prior to its sale" without the consent of the product's manufacturer, distributor or retailer. Consumer Product Protection Act of 2002, introduced last July by Rep. Melissa Hart (D-Penn.) and amended May 8, was spurred by recent product tampering cases primarily in the food industry. Speaking about the bill, Rep. Tammy Baldwin (D-Wisc.) notes "it has become clear that law enforcement officials lack the authority to prosecute these crimes under state or federal law." The Cosmetic, Toiletry & Fragrance Association supports the bill...
You may also be interested in...
Industry associations in the US and Canada have welcomed revisions to the proposed US-Mexico-Canada trade agreement that remove potentially damaging provisions around biologic data exclusivity and include measures favorable to generics, including incentives for generic competition.
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.